Literature DB >> 8869202

Serum insulin-like growth factor 1 in congenital heart disease.

J S Barton1, P C Hindmarsh, M A Preece.   

Abstract

Serum insulin-like growth factor 1 (IGF-1), insulin-like growth factor binding protein-3 (IGFBP-3), and a range of growth and nutritional variables were investigated in 62 infants with congenital heart disease and healthy controls. Infants with congenital heart disease were small, underweight, and had a reduced energy intake. Serum IGF-1 and IGFBP-3 concentrations were significantly reduced. Decreased IGF-1 and IGFBP-3 levels are observed in nutritional deficiency; similar findings in congenital heart disease suggest that undernutrition contributes to the poor growth of these infants. Serial measurements of serum IGF-1 and IGFBP-3 may be helpful in monitoring the effect of nutritional treatment in congenital heart disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8869202      PMCID: PMC1511626          DOI: 10.1136/adc.75.2.162

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

1.  Growth disturbance in congenital heart disease.

Authors:  A MEHRIZI; A DRASH
Journal:  J Pediatr       Date:  1962-09       Impact factor: 4.406

2.  24 h plasma levels of growth hormone in growth retardation of children with congenital heart disease.

Authors:  D D Ikkos; V Thanopoulos; D G Ikkos
Journal:  Helv Paediatr Acta       Date:  1974-12

Review 3.  Biological and immunological properties of insulin-like growth factors (IGF) I and II.

Authors:  J Zapf; C Schmid; E R Froesch
Journal:  Clin Endocrinol Metab       Date:  1984-03

4.  Decreased serum insulin-like growth factor-I associated with growth failure in newborn lambs with experimental cyanotic heart disease.

Authors:  D Bernstein; J R Jasper; R G Rosenfeld; R L Hintz
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

Review 5.  Insulin-like growth factor binding proteins in the human circulation: a review.

Authors:  R C Baxter
Journal:  Horm Res       Date:  1994

6.  Energy expenditure in congenital heart disease.

Authors:  J S Barton; P C Hindmarsh; C M Scrimgeour; M J Rennie; M A Preece
Journal:  Arch Dis Child       Date:  1994-01       Impact factor: 3.791

  6 in total
  6 in total

1.  Selection of cuffed endotracheal tube for children with congenital heart disease based on an ultrasound-based linear regression formula.

Authors:  Kan Zhang; Rui-Jing Ma; Ji-Jian Zheng; Yi-Qi Chen; Ma-Zhong Zhang
Journal:  J Clin Monit Comput       Date:  2018-09-28       Impact factor: 2.502

Review 2.  Measuring growth hormone and insulin-like growth factor-I in infants: what is normal?

Authors:  Colin Patrick Hawkes; Adda Grimberg
Journal:  Pediatr Endocrinol Rev       Date:  2013-12

Review 3.  The Role of GDF15 as a Myomitokine.

Authors:  Kornelia Johann; Maximilian Kleinert; Susanne Klaus
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

4.  Associations Between Blood Biomarkers, Cardiac Function, and Adverse Outcome in a Young Fontan Cohort.

Authors:  Eva van den Bosch; Sjoerd S M Bossers; Vivian P Kamphuis; Eric Boersma; Jolien W Roos-Hesselink; Johannes M P J Breur; Arend D J Ten Harkel; Livia Kapusta; Beatrijs Bartelds; Arno A W Roest; Irene M Kuipers; Nico A Blom; Laurens P Koopman; Willem A Helbing
Journal:  J Am Heart Assoc       Date:  2021-02-24       Impact factor: 5.501

5.  GDF15 is a heart-derived hormone that regulates body growth.

Authors:  Ting Wang; Jian Liu; Caitlin McDonald; Katherine Lupino; Xiandun Zhai; Benjamin J Wilkins; Hakon Hakonarson; Liming Pei
Journal:  EMBO Mol Med       Date:  2017-08       Impact factor: 12.137

Review 6.  Insulin-like Growth Factor and its Therapeutic Potential for Diabetes Complications - Mechanisms and Metabolic Links: A Review.

Authors:  Belete Biadgo; Workineh Tamir; Sintayehu Ambachew
Journal:  Rev Diabet Stud       Date:  2020-12-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.